NGVT vs. HWKN, PRM, IOSP, CC, HUN, ASH, BCPC, OLN, SCL, and ANDE
Should you be buying Ingevity stock or one of its competitors? The main competitors of Ingevity include Hawkins (HWKN), Perimeter Solutions (PRM), Innospec (IOSP), Chemours (CC), Huntsman (HUN), Ashland (ASH), Balchem (BCPC), Olin (OLN), Stepan (SCL), and Andersons (ANDE). These companies are all part of the "basic materials" sector.
Ingevity (NYSE:NGVT) and Hawkins (NASDAQ:HWKN) are both small-cap basic materials companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, community ranking, media sentiment, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation.
Ingevity received 162 more outperform votes than Hawkins when rated by MarketBeat users. Likewise, 65.39% of users gave Ingevity an outperform vote while only 59.28% of users gave Hawkins an outperform vote.
Hawkins has a net margin of 7.91% compared to Ingevity's net margin of -6.84%. Hawkins' return on equity of 19.54% beat Ingevity's return on equity.
In the previous week, Hawkins had 2 more articles in the media than Ingevity. MarketBeat recorded 10 mentions for Hawkins and 8 mentions for Ingevity. Ingevity's average media sentiment score of 1.13 beat Hawkins' score of -0.03 indicating that Ingevity is being referred to more favorably in the media.
Ingevity has a beta of 1.79, suggesting that its stock price is 79% more volatile than the S&P 500. Comparatively, Hawkins has a beta of 0.76, suggesting that its stock price is 24% less volatile than the S&P 500.
Hawkins has lower revenue, but higher earnings than Ingevity. Ingevity is trading at a lower price-to-earnings ratio than Hawkins, indicating that it is currently the more affordable of the two stocks.
91.6% of Ingevity shares are owned by institutional investors. Comparatively, 69.7% of Hawkins shares are owned by institutional investors. 1.1% of Ingevity shares are owned by company insiders. Comparatively, 3.6% of Hawkins shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Ingevity presently has a consensus target price of $55.00, indicating a potential upside of 0.95%. Hawkins has a consensus target price of $74.00, indicating a potential downside of 5.24%. Given Ingevity's higher possible upside, research analysts clearly believe Ingevity is more favorable than Hawkins.
Summary
Hawkins beats Ingevity on 10 of the 18 factors compared between the two stocks.
Get Ingevity News Delivered to You Automatically
Sign up to receive the latest news and ratings for NGVT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NGVT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Ingevity Competitors List
Related Companies and Tools
